Careful Selection of Patients Is Required to Obtain Higher Potential Benefit From Mepolizumab Therapy
- PMID: 33160530
- DOI: 10.1016/j.chest.2020.05.612
Careful Selection of Patients Is Required to Obtain Higher Potential Benefit From Mepolizumab Therapy
Comment in
-
Response.Chest. 2020 Nov;158(5):2230-2231. doi: 10.1016/j.chest.2020.06.061. Chest. 2020. PMID: 33160532 No abstract available.
Comment on
-
Real-World Effectiveness and the Characteristics of a "Super-Responder" to Mepolizumab in Severe Eosinophilic Asthma.Chest. 2020 Aug;158(2):491-500. doi: 10.1016/j.chest.2020.03.042. Epub 2020 Apr 8. Chest. 2020. PMID: 32275980
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
